Baxter's New Biopharma Baxalta to Have Headquarters in Illinois
Baxter announced that its new biopharmaceutical arm, scheduled to become independent from Baxter in 2015, will be located in Bannockburn, Illinois.
Baxalta will have sales of $6 billion next year in global revenues when it breaks away from Baxter in mid-2015, and the company just announced it will do the bulk of this business from its new headquarters in Northern Illinois. The lease for the 260,000-square-foot Bannockburn location will reportedly last more than 10 years.
The new company, which will have a focus on bleeding disorders and immunology, will be led by future Chief Executive Officer Ludwig Hantson, PhD, the current president of Baxter BioScience. He said in a statement that the selection of the Illinois location is a “key milestone on our journey to become a leading, independent biopharmaceutical company.”
Source:
Baxter
INTERPHEX 2025: Critical Role of Walk-In Chambers in Bio/Pharma Development and Manufacturing
April 3rd 2025Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, sat down with the PharmTech Group at INTERPHEX 2025 to discuss the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
